This dynamic infographic shares some of our key volume and outcomes data in these areas from 2019 and 2020.
Extended Dual Antiplatelet Therapy After PCI With DES Curbs MI but Boosts Bleeding
A large new meta-analysis suggests there’s no single best antiplatelet strategy for patients following percutaneous coronary intervention. We explore the nuances for clinicians to consider.
Radial-First STEMI Approach Need Not Compromise Door-to-Balloon Time
A review of Cleveland Clinic’s experience over six years shows that concerns that a radial-first approach to ST-elevation myocardial infarction will lengthen door-to-balloon times are unfounded.
Final EXCEL Results on Revascularization Choice in Left Main Disease: Interpret With Caution
Findings of equivalence in the largest-ever comparison of CABG and PCI for left main disease must be tempered by an understanding of study design limits and secondary outcomes, two cardiac surgeons contend.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Robotics in the Cardiac Cath Lab
Operator safety has been a driving force behind the development of robotic technology for cath lab procedures, but likely patient benefits appear to be emerging as well. We share our early insights.
PCI Does Not Impact Clinical Outcomes in Patients Undergoing TAVR, Meta-Analysis Finds
Percutaneous coronary intervention (PCI) at the time of transcatheter aortic valve replacement (TAVR) does not appear to increase TAVR risk, according to pooled results from 11 observational studies. But the safety question isn’t fully settled.
Optimal STEMI Outcomes Demand a Focus Beyond Door-to-Balloon Time
A new study shows the path to high-quality STEMI care is to consistently achieve a range of best practices, including guideline-directed medical therapy and high use of transradial access for PCI.
Outcomes Highlights in Coronary Artery and Peripheral Vascular Disease (Infographic)
Whether you’re looking for a benchmark or just plain curious, check out some of the latest volume and outcomes stats from our CABG, PCI and peripheral vascular disease programs.
Shared Decision-Making for Stable Angina: What the COURAGE Trial Can Teach Us
A cardiologist makes the case for a balanced approach to patient counseling that includes pros and cons of both optimal medical therapy and a PCI-first strategy.
PCI for Stable Angina: A Missed Opportunity for Shared Decision-making
Many patients and doctors do not fully understand the risks and benefits of PCI, even when presented with the evidence, and this makes informed consent challenging. Michael Rothberg, MD, MPH, explains why the best approach is shared decision-making.